IP Library Granted Patent US 9,040,487
Granted Patent B2
US 9,040,487 · App. 13/877,326 · Granted May 26, 2015

Cyclosporine emulsion

Inventor: Eskil Elmér (Lund, SE)
Assignee: NEUROVIVE PHARMACEUTICAL AB
A61K47/44A61K9/107A61K38/13A61K47/10A61K47/12A61K47/14A61K47/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,040,487
App. No.
13/877,326
Granted
May 26, 2015
Kind
B2
Abstract

The present invention relates to a cyclosporine emulsion containing: i) a cyclosporine ii) a natural oil (long chain triglyceride) iii) a phosphatidylcholine, iv) glycerol, v) a pharmaceutically tolerable alkali salt of a free fatty acid, vi) a medium chain triglyceride-oil vii) optionally, hydrochloric acid or sodium hydroxide for pH adjustment viii) water.

Claims (13)

1. A cyclosporine oil-in-water emulsion comprising

i) 5 g/L cyclosporine,

ii) 100 g/L soya bean oil,

iii) 12 g/L egg lecithin,

iv) 25 g/L water-free glycerol,

v) 0.3 g/L sodium oleate,

vi) 100 g/L medium chain triglyceride-oil selected from the group consisting of coconut oil, palm oil, and combinations thereof, and

vii) water for injection,

wherein the emulsion is isoosmolar and has an osmolarity of from 280 to 305 mosm/l, and

wherein the composition does not contain polyethoxylated castor oil.

2. The cyclosporine emulsion according to claim 1 having an osmolarity of from about 295 to about 300 mosm/1.

3. The emulsion according to claim 1 , wherein pH of the emulsion is from about 6 to about 8.8.

4. The cyclosporine emulsion of claim 1 , further comprising: hydrochloric acid or sodium hydroxide for pH adjustment.

Assignments (2)
CHANGE OF NAME Recorded Oct 22, 2020
From: NEUROVIVE PHARMACEUTICAL AB
To: ABLIVA AB
Reel/Frame 054175/0790 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2013
From: ELMER, ESKIL
To: NEUROVIVE PHARMACEUTICAL AB
Reel/Frame 031394/0527 →
Priority Claims (1)
DK 2010 00891 · Oct 1, 2010 · national
Continuity (2)
Provisional Application 61388633 · Oct 1, 2010
Related Publication 20130323270A1 · Dec 5, 2013